Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002040022-25-000002
Filing Date
2025-10-17
Accepted
2025-10-17 19:03:44
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4505
  Complete submission text file 0002040022-25-000002.txt   5953
Mailing Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747
Business Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747 848-201-5010
Apimeds Pharmaceuticals US, Inc. (Issuer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08425
Business Address
Kim Christopher (Reporting) CIK: 0002040022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42545 | Film No.: 251402073